Two decades of research on drug resistance in renal cell carcinoma
{{output}}
Background: Drug resistance in renal cell carcinoma (RCC) poses a major challenge to effective treatment. RCC drug resistance is primarily driven by genetic mutations, angiogenesis, immune suppression, metabolic reprogramming, an... ...
